Intra-Cellular Therapies Price Target Cut to $74.00/Share From $77.00 by Goldman Sachs
Intra-Cellular Therapies Price Target Cut to $74.00/Share From $77.00 by Goldman Sachs
高盛将Intra-Cellular Therapies的股票价格目标下调至74.00美元/股，之前为77.00美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册